Group One Trading, L.P. Acelrx Pharmaceuticals Inc Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
BUY
$0.2 - $0.35 $90 - $157
450 Added 1.84%
24,947 $5,000
Q2 2022

Aug 11, 2022
SELL
$0.18 - $0.29 $602 - $970
-3,346 Reduced 12.02%
24,497 $6,000
Q1 2022

May 12, 2022
SELL
$0.28 - $0.61 $168 - $366
-600 Reduced 2.11%
27,843 $8,000
Q4 2021

Feb 11, 2022
SELL
$0.49 - $1.02 $16 - $34
-34 Reduced 0.12%
28,443 $16,000
Q3 2021

Nov 12, 2021
BUY
$0.93 - $1.51 $26,483 - $43,000
28,477 New
28,477 $29,000
Q1 2021

May 12, 2021
SELL
$1.25 - $2.77 $40,147 - $88,966
-32,118 Closed
0 $0
Q4 2020

Feb 10, 2021
SELL
$1.18 - $1.98 $18,662 - $31,315
-15,816 Reduced 33.0%
32,118 $40,000
Q3 2020

Nov 12, 2020
BUY
$1.01 - $1.81 $32,546 - $58,325
32,224 Added 205.12%
47,934 $68,000
Q2 2020

Aug 13, 2020
SELL
$1.03 - $1.69 $16,019 - $26,284
-15,553 Reduced 49.75%
15,710 $19,000
Q1 2020

May 13, 2020
BUY
$0.76 - $2.07 $18,186 - $49,535
23,930 Added 326.33%
31,263 $37,000
Q4 2019

Feb 10, 2020
SELL
$1.66 - $2.4 $11,867 - $17,157
-7,149 Reduced 49.36%
7,333 $15,000
Q3 2019

Nov 12, 2019
SELL
$2.1 - $2.87 $609 - $832
-290 Reduced 1.96%
14,482 $32,000
Q2 2019

Aug 09, 2019
BUY
$2.1 - $3.93 $12,715 - $23,796
6,055 Added 69.46%
14,772 $37,000
Q1 2019

May 13, 2019
SELL
$2.35 - $3.83 $392,074 - $638,997
-166,840 Reduced 95.03%
8,717 $30,000
Q4 2018

Feb 06, 2019
BUY
$2.13 - $4.8 $342,955 - $772,857
161,012 Added 1106.99%
175,557 $406,000
Q3 2018

Nov 08, 2018
SELL
$2.6 - $4.6 $59,404 - $105,100
-22,848 Reduced 61.1%
14,545 $56,000
Q2 2018

Aug 14, 2018
BUY
$2.13 - $4.2 $79,647 - $157,050
37,393 New
37,393 $126,000
Q1 2018

May 11, 2018
SELL
$1.7 - $2.35 $25,865 - $35,755
-15,215 Closed
0 $0
Q4 2017

Feb 09, 2018
SELL
$1.75 - $5.5 $79,037 - $248,402
-45,164 Reduced 74.8%
15,215 $31,000
Q3 2017

Nov 15, 2017
BUY
$2.9 - $4.6 $151,055 - $239,604
52,088 Added 628.25%
60,379 $278,000
Q2 2017

Aug 14, 2017
BUY
N/A
8,291
8,291 $18,000

About ACELRX PHARMACEUTICALS INC

ACRX Quotes by TradingView
  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email